Can Brain-Derived Neurotrophic Factor Be Considered a Biomarker for Bipolar Disorder? An Analysis of the Current Evidence
- PMID: 37626577
- PMCID: PMC10452328
- DOI: 10.3390/brainsci13081221
Can Brain-Derived Neurotrophic Factor Be Considered a Biomarker for Bipolar Disorder? An Analysis of the Current Evidence
Abstract
Brain-derived neurotrophic factor (BDNF) plays a key role in brain development, contributing to neuronal survival and neuroplasticity. Previous works have found that BDNF is involved in several neurological or psychiatric diseases. In this review, we aimed to collect all available data on BDNF and bipolar disorder (BD) and assess if BDNF could be considered a biomarker for BD. We searched the most relevant medical databases and included studies reporting original data on BDNF circulating levels or Val66Met polymorphism. Only articles including a direct comparison with healthy controls (HC) and patients diagnosed with BD according to international classification systems were included. Of the 2430 identified articles, 29 were included in the present review. Results of the present review show a reduction in BDNF circulating levels during acute phases of BD compared to HC, which increase after effective therapy of the disorders. The Val66Met polymorphism was related to features usually associated with worse outcomes. High heterogeneity has been observed regarding sample size, clinical differences of included patients, and data analysis approaches, reducing comparisons among studies. Although more studies are needed, BDNF seems to be a promising biomarker for BD.
Keywords: BDNF; bipolar disorder; brain-derived neurotrophic factor.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.J Affect Disord. 2019 Jan 15;243:552-558. doi: 10.1016/j.jad.2018.07.054. Epub 2018 Jul 24. J Affect Disord. 2019. PMID: 30078664 Review.
-
Brain-derived Neurotrophic Factor (BDNF) and gray matter volume in bipolar disorder.Eur Psychiatry. 2017 Feb;40:33-37. doi: 10.1016/j.eurpsy.2016.06.008. Epub 2016 Nov 10. Eur Psychiatry. 2017. PMID: 27837670
-
Brain Derived Neurotrophic Factor and Cognitive Dysfunction in the Schizophrenia-Bipolar Spectrum: A Systematic Review and Meta-Analysis.Front Psychiatry. 2022 May 24;13:827322. doi: 10.3389/fpsyt.2022.827322. eCollection 2022. Front Psychiatry. 2022. PMID: 35686181 Free PMC article.
-
Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele.J Affect Disord. 2016 Jul 1;198:198-205. doi: 10.1016/j.jad.2016.03.044. Epub 2016 Mar 10. J Affect Disord. 2016. PMID: 27018938 Free PMC article.
-
Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women.J Affect Disord. 2014 Mar;156:214-8. doi: 10.1016/j.jad.2013.01.054. Epub 2013 Dec 21. J Affect Disord. 2014. PMID: 24398043 Free PMC article.
Cited by
-
Biological correlates of treatment resistant depression: a review of peripheral biomarkers.Front Psychiatry. 2023 Oct 24;14:1291176. doi: 10.3389/fpsyt.2023.1291176. eCollection 2023. Front Psychiatry. 2023. PMID: 37941970 Free PMC article. Review.
-
Serum BDNF, depressive symptoms, sleep quality, and cognitive function: a study on their impact and predictive value for suicidal ideation in bipolar depressive disorder patients.Eur Arch Psychiatry Clin Neurosci. 2025 Apr 2. doi: 10.1007/s00406-025-01997-y. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2025. PMID: 40172689
-
Job burnout, cognitive functioning, and Brain-derived neurotrophic factor expression among hospital Mexican nurses.PLoS One. 2024 May 24;19(5):e0304092. doi: 10.1371/journal.pone.0304092. eCollection 2024. PLoS One. 2024. PMID: 38787900 Free PMC article.
References
-
- Institute of Health Metrics and Evaluation Global Health Data Exchange (GHDx) [(accessed on 4 March 2023)]. Available online: https://vizhub.healthdata.org/gbd-results/
-
- Merikangas K.R., Jin R., He J.-P., Kessler R.C., Lee S., Sampson N.A., Viana M.C., Andrade L.H., Hu C., Karam E.G., et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch. Gen. Psychiatry. 2011;68:241–251. doi: 10.1001/archgenpsychiatry.2011.12. - DOI - PMC - PubMed
-
- McIntyre R.S., Alda M., Baldessarini R.J., Bauer M., Berk M., Correll C.U., Fagiolini A., Fountoulakis K., Frye M.A., Grunze H., et al. The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. World Psychiatry. 2022;21:364–387. doi: 10.1002/wps.20997. - DOI - PMC - PubMed
-
- Lång U., Ramsay H., Yates K., Veijola J., Gyllenberg D., Clarke M.C., Leacy F.P., Gissler M., Kelleher I. Potential for prediction of psychosis and bipolar disorder in Child and Adolescent Mental Health Services: A longitudinal register study of all people born in Finland in 1987. World Psychiatry. 2022;21:436–443. doi: 10.1002/wps.21009. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources